Garg U C, Hassid A
Department of Pharmacology, University of Tennessee, Memphis 38163.
Am J Physiol. 1989 Jul;257(1 Pt 2):F60-6. doi: 10.1152/ajprenal.1989.257.1.F60.
Recent studies indicate that endothelium-derived relaxing factor (EDRF) may be identical with nitric oxide (NO). The purpose of this study was to investigate the antimitogenic effect of NO-generating drugs in cultured mesangial cells. S-nitroso-N-acetylpenicillamine, sodium nitroprusside, and isosorbide dinitrate, which generate NO, dose dependently inhibited serum-stimulated DNA synthesis. All three drugs also inhibited the rate of cell proliferation, whereas sodium nitroprusside and S-nitroso-N-acetylpenicillamine decreased cell density at confluence. The antimitogenic activity of S-nitroso-N-acetylpenicillamine was labile in culture medium and could be inhibited by hemoglobin, supporting the view that NO, in free or bound form, was the ultimate effector. All three vasodilators increased cellular guanosine 3',5'-cyclic monophosphate (cGMP) levels dose dependently; moreover, 8-bromo-cGMP mimicked the effects of the NO-generating drugs, suggesting that cGMP may be an intracellular mediator of antimitogenesis. The growth-inhibitory effect of S-nitroso-N-acetylpenicillamine was reversible and was not due to cell toxicity as shown by several criteria of cell viability. The results raise the possibility that EDRF/NO may be a modulator of mesangial cell growth in vivo.
最近的研究表明,内皮源性舒张因子(EDRF)可能与一氧化氮(NO)相同。本研究的目的是探讨产生NO的药物对培养的系膜细胞的抗增殖作用。能产生NO的亚硝基-N-乙酰青霉胺、硝普钠和硝酸异山梨酯剂量依赖性地抑制血清刺激的DNA合成。这三种药物均抑制细胞增殖速率,而硝普钠和亚硝基-N-乙酰青霉胺降低汇合时的细胞密度。亚硝基-N-乙酰青霉胺的抗增殖活性在培养基中不稳定,可被血红蛋白抑制,支持游离或结合形式的NO是最终效应物的观点。这三种血管扩张剂均剂量依赖性地增加细胞内环磷酸鸟苷(cGMP)水平;此外,8-溴-cGMP模拟了产生NO药物的作用,提示cGMP可能是抗增殖作用的细胞内介质。亚硝基-N-乙酰青霉胺的生长抑制作用是可逆的,且不是由细胞毒性引起的,这一点通过多种细胞活力标准得以证明。这些结果提示EDRF/NO可能是体内系膜细胞生长的调节剂。